Fair call, though don't they forward project rest of period rent into payables? If that's the case then it's still worth considering what the true state of affairs might be at year's end. It seems that FCF could be the issue for FY23, but with one offs for stores, eroma and NZ. As others have said revenue is steady, so we're probably suffering from CODB inflation and COGS inflation, and they'll need to see if they can pass some of that on to the customer without affecting volume... but as long as they are profitable and not FCF negative, I'm still hopeful that true value is much higher than this.
- Forums
- ASX - By Stock
- DSK
- Ann: Trading Update
Ann: Trading Update, page-48
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DSK (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.17 |
Change
0.030(2.63%) |
Mkt cap ! $72.85M |
Open | High | Low | Value | Volume |
$1.15 | $1.18 | $1.14 | $101.5K | 87.55K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8569 | $1.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.18 | 22000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8569 | 1.170 |
1 | 3000 | 1.165 |
1 | 5000 | 1.160 |
1 | 14000 | 1.140 |
1 | 381 | 1.135 |
Price($) | Vol. | No. |
---|---|---|
1.175 | 22000 | 1 |
1.220 | 40000 | 1 |
1.240 | 7896 | 2 |
1.250 | 21000 | 2 |
1.255 | 30000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
DSK (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online